title: Oral contraceptives and myocardial infarction: results of the MICA case-control study.
abstract: OBJECTIVE
  To determine the association between myocardial infarction and use of different types of oral contraception in young women.
  
  
  METHODS
  Community based case-control study. Data from interviews and general practice records.
  
  
  METHODS
  England, Scotland, and Wales.
  
  
  METHODS
  Cases (n=448) were recruited from women aged between 16 and 44 who had suffered an incident myocardial infarction between 1 October 1993 and 16 October 1995. Controls (n=1728) were women without a diagnosis of myocardial infarction matched for age and general practice.
  
  
  METHODS
  Odds ratios for myocardial infarction in current users of all combined oral contraceptives stratified by their progestagen content compared with non-users; current users of third generation versus second generation oral contraceptives.
  
  
  RESULTS
  The adjusted odds ratio for myocardial infarction was 1.40 (95% confidence interval 0.78 to 2. 52) for all combined oral contraceptive users, 1.10 (0.52 to 2.30) for second generation users, and 1.96 (0.87 to 4.39) for third generation users. Subgroup analysis by progestagen content did not show any significant difference from 1, and there was no effect of duration of use. The adjusted odds ratio for third generation users versus second generation users was 1.78 (0.66 to 4.83). 87% of cases were not exposed to an oral contraceptive, and 88% had clinical cardiovascular risk factors or were smokers, or both. Smoking was strongly associated with myocardial infarction: adjusted odds ratio 12.5 (7.29 to 21.5) for smoking 20 or more cigarettes a day.
  
  
  CONCLUSIONS
  There was no significant association between the use of oral contraceptives and myocardial infarction. The modest and non-significant point estimates for this association have wide confidence intervals. There was no significant difference between second and third generation products.
authors.affiliation: Drug Safety Research Unit, Bursledon Hall, Southampton SO31 1AA.
authors.forename: N
authors.initials: N
authors.lastname: Dunn
authors.forename: M
authors.initials: M
authors.lastname: Thorogood
authors.forename: B
authors.initials: B
authors.lastname: Faragher
authors.forename: L
authors.initials: L
authors.lastname: de Caestecker
authors.forename: T M
authors.initials: TM
authors.lastname: MacDonald
authors.forename: C
authors.initials: C
authors.lastname: McCollum
authors.forename: S
authors.initials: S
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Mann
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D003277:Contraceptives, Oral, Combined